Free Trial
→ Musk’s Project Colossus could mint millionaires (From Brownstone Research) (Ad) Buy BOW Stock  Free BOW Stock Alerts

Bowhead Specialty (BOW) Financials

Bowhead Specialty logo
$37.17 +0.67 (+1.84%)
Closing price 03:59 PM Eastern
Extended Trading
$37.19 +0.02 (+0.05%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Bowhead Specialty

Annual Income Statements for Bowhead Specialty

This table shows Bowhead Specialty's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders		 38 25 11
Consolidated Net Income / (Loss)		 38 25 11
Net Income / (Loss) Continuing Operations		 38 25 11
Total Pre-Tax Income 		51 32 15
Total Operating Income		 88 54 30
Total Gross Profit		 178 117 76
Total Revenue		 426 283 188
Operating Revenue		 426 283 188
Total Cost of Revenue		 248 166 112
Operating Cost of Revenue		 248 166 112
Total Operating Expenses		 89 63 46
Other Operating Expenses / (Income)		 89 63 46
Total Other Income / (Expense), net		 -38 -22 -15
Interest Expense		 0.73 0.00 0.00
Other Income / (Expense), net		 -37 -22 -15
Income Tax Expense		 12 7.07 3.41
Basic Earnings per Share		 $1.31 $1.04 $0.47
Weighted Average Basic Shares Outstanding		 29.26M 24M 24M
Diluted Earnings per Share		 $1.29 $1.04 $0.47
Weighted Average Diluted Shares Outstanding		 29.68M 24M 24M
Weighted Average Basic & Diluted Shares Outstanding		 32.66M - -

Quarterly Income Statements for Bowhead Specialty

This table shows Bowhead Specialty's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q3 2023 Q2 2023
Period end date 3/31/2025 9/30/2024 6/30/2024 9/30/2023 6/30/2023
Net Income / (Loss) Attributable to Common Shareholders		 11 12 5.53 8.71 6.56
Consolidated Net Income / (Loss)		 11 12 5.53 8.71 6.56
Net Income / (Loss) Continuing Operations		 11 12 5.53 8.71 6.56
Total Pre-Tax Income 		14 16 7.41 11 8.46
Total Operating Income		 25 27 17 17 13
Total Gross Profit		 49 49 40 33 28
Total Revenue		 123 117 99 76 65
Operating Revenue		 123 117 99 76 65
Total Cost of Revenue		 73 68 59 43 37
Operating Cost of Revenue		 73 68 59 43 37
Total Operating Expenses		 24 22 23 16 15
Other Operating Expenses / (Income)		 24 22 23 16 15
Total Other Income / (Expense), net		 -11 -11 -9.62 -5.66 -4.97
Interest Expense		 0.25 0.25 0.22 0.00 0.00
Other Income / (Expense), net		 -11 -10 -9.39 -5.66 -4.97
Income Tax Expense		 3.05 3.73 1.88 2.56 1.91
Basic Earnings per Share		 $0.35 $0.37 $0.20 $0.36 $0.27
Weighted Average Basic Shares Outstanding		 32.66M 32.66M 27.65M 24M 24M
Diluted Earnings per Share		 $0.34 $0.36 $0.20 $0.36 $0.27
Weighted Average Diluted Shares Outstanding		 33.71M 33.26M 27.77M 24M 24M
Weighted Average Basic & Diluted Shares Outstanding		 32.66M 32.66M 32.66M - -

Annual Cash Flow Statements for Bowhead Specialty

This table details how cash moves in and out of Bowhead Specialty's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Change in Cash & Equivalents		 102 39 -6.81
Net Cash From Operating Activities		 294 236 182
Net Cash From Continuing Operating Activities		 294 236 182
Net Income / (Loss) Continuing Operations		 38 25 11
Consolidated Net Income / (Loss)		 38 25 11
Depreciation Expense		 3.87 2.27 0.73
Amortization Expense		 -3.51 -2.85 -0.07
Non-Cash Adjustments To Reconcile Net Income		 267 224 175
Changes in Operating Assets and Liabilities, net		 -11 -13 -5.31
Net Cash From Investing Activities		 -326 -275 -187
Net Cash From Continuing Investing Activities		 -326 -275 -187
Purchase of Property, Plant & Equipment		 -3.11 -3.82 -3.97
Purchase of Investments		 -613 -367 -198
Sale and/or Maturity of Investments		 290 96 15
Net Cash From Financing Activities		 134 78 -1.00
Net Cash From Continuing Financing Activities		 134 78 -1.00
Payment of Dividends		 0.00 0.00 -25
Issuance of Common Equity		 131 0.00 0.00
Other Financing Activities, net		 2.90 78 24
Cash Income Taxes Paid		 16 14 5.29

Quarterly Cash Flow Statements for Bowhead Specialty

This table details how cash moves in and out of Bowhead Specialty's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q4 2023 Q3 2023
Period end date 3/31/2025 12/31/2024 9/30/2024 12/31/2023 9/30/2023
Net Change in Cash & Equivalents		 -99 60 -37 -15 52
Net Cash From Operating Activities		 48 61 119 61 88
Net Cash From Continuing Operating Activities		 48 62 119 62 88
Net Income / (Loss) Continuing Operations		 11 14 12 4.78 8.71
Consolidated Net Income / (Loss)		 11 14 12 4.78 8.71
Depreciation Expense		 0.40 1.10 1.05 0.81 0.78
Amortization Expense		 -0.37 -0.58 -0.86 -1.01 -0.76
Non-Cash Adjustments To Reconcile Net Income		 49 292 23 219 -79
Changes in Operating Assets and Liabilities, net		 -13 -244 84 -161 158
Net Cash From Investing Activities		 -146 -1.14 -157 -101 -59
Net Cash From Continuing Investing Activities		 -146 -1.14 -157 -101 -59
Purchase of Property, Plant & Equipment		 -1.23 -0.51 -1.01 -0.92 -1.09
Purchase of Investments		 -251 -145 -239 -128 -62
Sale and/or Maturity of Investments		 105 144 83 28 3.86
Net Cash From Financing Activities		 0.00 0.06 - 25 22
Net Cash From Continuing Financing Activities		 0.00 0.06 - 25 22
Other Financing Activities, net		 0.00 0.06 - 25 22

Annual Balance Sheets for Bowhead Specialty

This table presents Bowhead Specialty's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023
Period end date 12/31/2024 12/31/2023
Total Assets		 1,654 1,028
Total Current Assets		 559 313
Cash & Equivalents		 97 118
Restricted Cash		 125 1.70
Short-Term Investments		 18 13
Current Deferred & Refundable Income Taxes		 0.59 1.11
Other Current Assets		 319 178
Plant, Property, & Equipment, net		 6.85 7.60
Total Noncurrent Assets		 1,098 717
Noncurrent Deferred & Refundable Income Taxes		 20 14
Other Noncurrent Operating Assets		 1,078 702
Total Liabilities & Shareholders' Equity		 1,654 1,028
Total Liabilities		 1,284 836
Total Current Liabilities		 1,275 831
Accrued Expenses		 18 15
Current Deferred & Payable Income Tax Liabilities		 1.57 0.04
Other Current Liabilities		 1,256 816
Total Noncurrent Liabilities		 8.65 4.51
Other Noncurrent Operating Liabilities		 8.65 4.51
Commitments & Contingencies		 0.00 0.00
Redeemable Noncontrolling Interest		 0.27 0.00
Total Equity & Noncontrolling Interests		 370 192
Total Preferred & Common Equity		 370 192
Total Common Equity		 370 192
Common Stock		 318 179
Retained Earnings		 63 25
Accumulated Other Comprehensive Income / (Loss)		 -11 -11

Quarterly Balance Sheets for Bowhead Specialty

This table presents Bowhead Specialty's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024
Period end date 3/31/2025 9/30/2024 6/30/2024
Total Assets		 1,753 1,548 1,395
Total Current Assets		 500 451 481
Cash & Equivalents		 88 133 180
Restricted Cash		 35 29 18
Short-Term Investments		 18 17 19
Current Deferred & Refundable Income Taxes		 0.61 0.33 1.32
Other Current Assets		 358 272 262
Plant, Property, & Equipment, net		 7.68 7.44 7.48
Total Noncurrent Assets		 1,256 1,099 919
Noncurrent Deferred & Refundable Income Taxes		 19 16 17
Other Noncurrent Operating Assets		 1,236 1,083 902
Total Liabilities & Shareholders' Equity		 1,753 1,548 1,395
Total Liabilities		 1,362 1,183 1,055
Total Current Liabilities		 1,352 1,176 1,037
Accrued Expenses		 5.78 15 11
Current Deferred & Payable Income Tax Liabilities		 5.60 0.03 0.03
Other Current Liabilities		 1,341 1,161 1,025
Total Noncurrent Liabilities		 9.41 7.29 18
Other Noncurrent Operating Liabilities		 9.41 7.29 18
Commitments & Contingencies		 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 0.41 0.16 0.05
Total Equity & Noncontrolling Interests		 391 365 340
Total Preferred & Common Equity		 391 365 340
Total Common Equity		 391 365 340
Common Stock		 320 317 315
Retained Earnings		 74 49 37
Accumulated Other Comprehensive Income / (Loss)		 -3.74 -1.29 -12

Annual Metrics And Ratios for Bowhead Specialty

This table displays calculated financial ratios and metrics derived from Bowhead Specialty's official financial filings.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Growth Metrics		 - - -
Revenue Growth		 50.20% 51.06% 0.00%
EBITDA Growth		 63.69% 105.87% 0.00%
EBIT Growth		 59.61% 119.05% 0.00%
NOPAT Growth		 59.94% 82.58% 0.00%
Net Income Growth		 52.69% 122.52% 0.00%
EPS Growth		 24.04% 121.28% 0.00%
Operating Cash Flow Growth		 24.58% 30.05% 0.00%
Free Cash Flow Firm Growth		 75.66% 0.00% 0.00%
Invested Capital Growth		 108.23% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00%
Profitability Metrics		 - - -
Gross Margin		 41.71% 41.33% 40.43%
EBITDA Margin		 12.13% 11.13% 8.17%
Operating Margin		 20.78% 18.93% 15.91%
EBIT Margin		 12.04% 11.33% 7.81%
Profit (Net Income) Margin		 8.98% 8.84% 6.00%
Tax Burden Percent		 75.68% 77.99% 76.78%
Interest Burden Percent		 98.59% 100.00% 100.00%
Effective Tax Rate		 24.32% 22.01% 23.22%
Return on Invested Capital (ROIC)		 64.20% 123.73% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 80.41% 150.74% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -50.60% -97.65% 0.00%
Return on Equity (ROE)		 13.60% 26.08% 0.00%
Cash Return on Invested Capital (CROIC)		 -6.02% -76.27% 0.00%
Operating Return on Assets (OROA)		 3.82% 3.12% 0.00%
Return on Assets (ROA)		 2.85% 2.44% 0.00%
Return on Common Equity (ROCE)		 13.59% 26.08% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 10.33% 13.04% 0.00%
Net Operating Profit after Tax (NOPAT)		 67 42 23
NOPAT Margin		 15.72% 14.77% 12.22%
Net Nonoperating Expense Percent (NNEP)		 -16.21% -27.01% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 18.08% 21.79% -
Cost of Revenue to Revenue		 58.29% 58.67% 59.57%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 20.94% 22.39% 24.51%
Earnings before Interest and Taxes (EBIT)		 51 32 15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 52 32 15
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 3.13 0.67 0.00
Price to Tangible Book Value (P/TBV)		 3.13 0.67 0.00
Price to Revenue (P/Rev)		 2.73 0.45 0.68
Price to Earnings (P/E)		 30.33 5.11 11.37
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 3.30% 19.57% 8.79%
Enterprise Value to Invested Capital (EV/IC)		 6.54 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 2.16 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 17.84 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 17.96 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 13.76 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 3.13 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00
Financial Leverage		 -0.63 -0.65 0.00
Leverage Ratio		 4.77 5.35 0.00
Compound Leverage Factor		 4.70 5.35 0.00
Debt to Total Capital		 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.07% 0.00% 0.00%
Common Equity to Total Capital		 99.93% 100.00% 0.00%
Debt to EBITDA		 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00
Altman Z-Score		 0.44 -0.10 0.00
Noncontrolling Interest Sharing Ratio		 0.05% 0.00% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 0.44 0.38 0.00
Quick Ratio		 0.09 0.16 0.00
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 -6.28 -26 0.00
Operating Cash Flow to CapEx		 9,456.52% 6,185.52% 4,573.11%
Free Cash Flow to Firm to Interest Expense		 -8.66 0.00 0.00
Operating Cash Flow to Interest Expense		 405.91 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 401.62 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.32 0.28 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00
Fixed Asset Turnover		 58.93 37.28 0.00
Accounts Payable Turnover		 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00
Capital & Investment Metrics		 - - -
Invested Capital		 141 68 0.00
Invested Capital Turnover		 4.08 8.38 0.00
Increase / (Decrease) in Invested Capital		 73 68 0.00
Enterprise Value (EV)		 921 -5.25 0.00
Market Capitalization		 1,160 128 128
Book Value per Share		 $11.33 $8.00 $0.00
Tangible Book Value per Share		 $11.33 $8.00 $0.00
Total Capital		 370 192 0.00
Total Debt		 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00
Net Debt		 -240 -133 0.00
Capital Expenditures (CapEx)		 3.11 3.82 3.97
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -956 -652 0.00
Debt-free Net Working Capital (DFNWC)		 -716 -519 0.00
Net Working Capital (NWC)		 -716 -519 0.00
Net Nonoperating Expense (NNE)		 29 17 12
Net Nonoperating Obligations (NNO)		 -230 -124 0.00
Total Depreciation and Amortization (D&A)		 0.36 -0.58 0.66
Debt-free, Cash-free Net Working Capital to Revenue		 -224.55% -230.05% 0.00%
Debt-free Net Working Capital to Revenue		 -168.27% -183.03% 0.00%
Net Working Capital to Revenue		 -168.27% -183.03% 0.00%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $1.31 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 29.26M 0.00 0.00
Adjusted Diluted Earnings per Share		 $1.29 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 29.68M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 32.66M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 67 42 23
Normalized NOPAT Margin		 15.72% 14.77% 12.22%
Pre Tax Income Margin		 11.87% 11.33% 7.81%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 70.70 0.00 0.00
NOPAT to Interest Expense		 92.32 0.00 0.00
EBIT Less CapEx to Interest Expense		 66.41 0.00 0.00
NOPAT Less CapEx to Interest Expense		 88.03 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 222.10%
Augmented Payout Ratio		 0.00% 0.00% 222.10%

Quarterly Metrics And Ratios for Bowhead Specialty

This table displays calculated financial ratios and metrics derived from Bowhead Specialty's official financial filings.

Metric Q1 2025 Q3 2024 Q2 2024 Q3 2023 Q2 2023
Period end date 3/31/2025 9/30/2024 6/30/2024 9/30/2023 6/30/2023
Growth Metrics		 - - - - -
Revenue Growth		 35.34% 53.45% 51.10% 0.00% 0.00%
EBITDA Growth		 67.94% 44.10% -9.76% 0.00% 0.00%
EBIT Growth		 62.51% 42.68% -9.76% 0.00% 0.00%
NOPAT Growth		 63.31% 55.14% 22.18% 0.00% 0.00%
Net Income Growth		 62.94% 38.86% -15.59% 0.00% 0.00%
EPS Growth		 17.24% 0.00% -25.93% 0.00% 0.00%
Operating Cash Flow Growth		 13.87% 35.32% 0.00% 0.00% 0.00%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 18.06% 0.00% 16.26% 0.00%
EBITDA Q/Q Growth		 0.00% 112.97% 0.00% 33.36% 0.00%
EBIT Q/Q Growth		 0.00% 110.53% 0.00% 33.14% 0.00%
NOPAT Q/Q Growth		 0.00% 59.64% 0.00% 25.73% 0.00%
Net Income Q/Q Growth		 0.00% 118.54% 0.00% 32.85% 0.00%
EPS Q/Q Growth		 0.00% 80.00% 0.00% 33.33% 0.00%
Operating Cash Flow Q/Q Growth		 -22.30% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% -44.43% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 45.87% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - -
Gross Margin		 40.17% 41.91% 40.32% 43.76% 42.85%
EBITDA Margin		 12.02% 13.92% 7.72% 14.83% 12.93%
Operating Margin		 20.66% 22.74% 17.21% 22.24% 20.52%
EBIT Margin		 11.99% 13.76% 7.72% 14.80% 12.93%
Profit (Net Income) Margin		 9.31% 10.36% 5.59% 11.44% 10.01%
Tax Burden Percent		 78.96% 76.43% 74.67% 77.31% 77.48%
Interest Burden Percent		 98.32% 98.43% 97.07% 100.00% 100.00%
Effective Tax Rate		 21.04% 23.57% 25.33% 22.69% 22.52%
Return on Invested Capital (ROIC)		 57.38% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 70.48% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -23.62% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 33.76% 0.00% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 3.13% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 2.43% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 33.73% 0.00% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 10.91% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 20 20 13 13 10
NOPAT Margin		 16.31% 17.38% 12.85% 17.19% 15.90%
Net Nonoperating Expense Percent (NNEP)		 -13.10% -9.72% -6.99% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 5.12% - - - -
Cost of Revenue to Revenue		 59.84% 58.09% 59.68% 56.24% 57.15%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 19.51% 19.17% 23.11% 21.52% 22.33%
Earnings before Interest and Taxes (EBIT)		 15 16 7.63 11 8.46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 15 16 7.63 11 8.46
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 3.40 2.51 0.56 0.00 0.00
Price to Tangible Book Value (P/TBV)		 3.40 2.51 0.56 0.00 0.00
Price to Revenue (P/Rev)		 2.90 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 31.13 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 3.21% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 4.56 3.76 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 2.59 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 20.61 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 20.85 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 15.89 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 3.96 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.34 -0.46 -0.60 0.00 0.00
Leverage Ratio		 4.48 4.24 4.10 0.00 0.00
Compound Leverage Factor		 4.40 4.18 3.98 0.00 0.00
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.10% 0.04% 0.01% 0.00% 0.00%
Common Equity to Total Capital		 99.90% 99.96% 99.99% 0.00% 0.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.35 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.10% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - -
Current Ratio		 0.37 0.38 0.46 0.00 0.00
Quick Ratio		 0.08 0.13 0.19 0.00 0.00
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 -240 -176 -122 0.00 0.00
Operating Cash Flow to CapEx		 3,870.40% 11,873.66% 0.00% 8,105.69% 0.00%
Free Cash Flow to Firm to Interest Expense		 -972.55 -697.22 -543.09 0.00 0.00
Operating Cash Flow to Interest Expense		 193.21 474.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 188.21 470.01 0.00 0.00 0.00
Efficiency Ratios		 - - - - -
Asset Turnover		 0.26 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 59.62 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - -
Invested Capital		 260 196 134 0.00 0.00
Invested Capital Turnover		 3.52 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 260 196 134 0.00 0.00
Enterprise Value (EV)		 1,187 736 -27 0.00 0.00
Market Capitalization		 1,328 915 191 128 128
Book Value per Share		 $11.97 $11.17 $12.29 $0.00 $0.00
Tangible Book Value per Share		 $11.97 $11.17 $12.29 $0.00 $0.00
Total Capital		 391 365 340 0.00 0.00
Total Debt		 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00
Net Debt		 -141 -179 -218 0.00 0.00
Capital Expenditures (CapEx)		 1.23 1.01 0.00 1.09 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -994 -904 -774 0.00 0.00
Debt-free Net Working Capital (DFNWC)		 -852 -725 -556 0.00 0.00
Net Working Capital (NWC)		 -852 -725 -556 0.00 0.00
Net Nonoperating Expense (NNE)		 8.59 8.20 7.18 4.37 3.85
Net Nonoperating Obligations (NNO)		 -131 -169 -206 0.00 0.00
Total Depreciation and Amortization (D&A)		 0.04 0.19 0.00 0.02 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 -217.08% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 -186.25% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 -186.25% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 $0.35 $0.37 $0.20 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 32.66M 32.66M 27.65M 0.00 0.00
Adjusted Diluted Earnings per Share		 $0.34 $0.36 $0.20 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 33.71M 33.26M 27.77M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 32.66M 32.66M 32.66M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 20 20 13 13 10
Normalized NOPAT Margin		 16.31% 17.38% 12.85% 17.19% 15.90%
Pre Tax Income Margin		 11.79% 13.55% 7.49% 14.80% 12.93%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 59.58 63.78 34.08 0.00 0.00
NOPAT to Interest Expense		 81.04 80.53 56.75 0.00 0.00
EBIT Less CapEx to Interest Expense		 54.59 59.79 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 76.05 76.54 0.00 0.00 0.00
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Bowhead Specialty's Financials

When does Bowhead Specialty's financial year end?

According to the most recent income statement we have on file, Bowhead Specialty's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Bowhead Specialty's net income changed over the last 2 years?

Bowhead Specialty's net income appears to be on an upward trend, with a most recent value of $38.24 million in 2024, rising from $11.26 million in 2022. The previous period was $25.05 million in 2023. See where experts think Bowhead Specialty is headed by visiting Bowhead Specialty's forecast page.

What is Bowhead Specialty's operating income?
Bowhead Specialty's total operating income in 2024 was $88.45 million, based on the following breakdown:
  • Total Gross Profit: $177.56 million
  • Total Operating Expenses: $89.11 million
How has Bowhead Specialty revenue changed over the last 2 years?

Over the last 2 years, Bowhead Specialty's total revenue changed from $187.60 million in 2022 to $425.66 million in 2024, a change of 126.9%.

How much debt does Bowhead Specialty have?

Bowhead Specialty's total liabilities were at $1.28 billion at the end of 2024, a 53.6% increase from 2023, and a 53.6% increase since 2023.

How much cash does Bowhead Specialty have?

In the past 1 years, Bowhead Specialty's cash and equivalents has ranged from $97.48 million in 2024 to $118.07 million in 2023, and is currently $97.48 million as of their latest financial filing in 2024.

How has Bowhead Specialty's book value per share changed over the last 2 years?

Over the last 2 years, Bowhead Specialty's book value per share changed from 0.00 in 2022 to 11.33 in 2024, a change of 1,133.5%.


Related Companies

This page (NYSE:BOW) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored